Table 1.
Comparative analysis of patients with MELD greater or less than 32.
| MELD ≥ 32 (n = 10) | MELD < 32 (n = 10) | t/Z value | P value | |
|---|---|---|---|---|
| MPO (%) | 0.0806 (0.05195, 0.2874) | 0.0151 (0.00, 0.08675) | −2.125 | 0.034∗ |
| RIPK3 (%) | 4.7367 (1.7054, 6.2929) | 2.0914 (1.4491, 4.7188) | −0.735 | 0.462 |
| Ishak score | 6.75 (5.125, 9.000) | 4.00 (3.25, 5.75) | −1.847 | 0.065 |
| Ishak fibrosis score | 6.00 (6.00, 6.00) | 6.00 (5.5, 6.0) | −0.860 | 0.390 |
| Knodell score | 11.3 ± 2.7305 | 9.222 ± 2.1667 | −1.823 | 0.086 |
| AHHS score | 6.70 ± 1.11056 | 6.3889 ± 1.21906 | −0.582 | 0.568 |
| ALD grading | 6.90 ± 2.3781 | 5.556 ± 1.5899 | −1.431 | 0.171 |
| ALD stage | 6.00 (5.00, 6.00) | 6.00 (5.00, 6.00) | −0.159 | 0.874 |
MPO: myeloperoxidase; RIPK3: receptor-interacting protein kinase3; MELD: model for end-stage liver disease; AHHS: alcoholic hepatitis histologic score. ∗p < 0.05.